World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
33557
World Ranking
12570
National Ranking
478

Overview

Stefano Cascinu is affiliated with Vita-Salute San Raffaele University in Italy. Their research primarily focuses on the field of Medicine, with a significant concentration in Oncology, Surgery, Pulmonary and Respiratory Medicine, Hepatology, and Cancer Research.

The main topics covered by their work include:

  • Hepatocellular Carcinoma Treatment and Prognosis
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Colorectal Cancer Treatments and Studies
  • Pancreatic and Hepatic Oncology Research
  • Gastric Cancer Management and Outcomes
  • Cancer Genomics and Diagnostics
  • Genetic factors in colorectal cancer

Stefano Cascinu has contributed to publications in a variety of academic journals. The most frequent venues include:

  • Annals of Oncology
  • Targeted Oncology
  • Cancers
  • European Journal of Cancer
  • HPB

Some recent papers with details on their publication year and venue are:

  • Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up, 2022, Annals of Oncology
  • Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis, 2022, ESMO Open
  • Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population, 2022, European Journal of Cancer
  • Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data, 2023, Liver International
  • Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes, 2020, The Oncologist

The scientist frequently collaborates with other researchers. The most common coauthors associated with their work are:

  • Andrea Casadei-Gardini
  • Mario Scartozzi
  • Margherita Rimini
  • Sara Lonardi
  • Valentina Burgio

Best Publications

  • Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status

    Eric Van Cutsem;Claus Henning Köhne;István Láng;Gunnar Folprecht

  • Addressing the challenges of pancreatic cancer: future directions for improving outcomes

    Manuel Hidalgo;Stefano Cascinu;Jörg Kleeff;Roberto Labianca

  • Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study.

    Timothy J Price;Marc Peeters;Tae Won Kim;Jin Li

  • PTEN Expression and KRAS Mutations on Primary Tumors and Metastases in the Prediction of Benefit From Cetuximab Plus Irinotecan for Patients With Metastatic Colorectal Cancer

    Fotios Loupakis;Luca Pollina;Irene Stasi;Annamaria Ruzzo

  • Randomized phase III study of irinotecan and 5-FU/FA with or without cetuximab in the first-line treatment of patients with metastatic colorectal cancer (mCRC): The CRYSTAL trial

    E. Van Cutsem;M. Nowacki;I. Lang;S. Cascinu

  • Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: A meta-analysis of published randomised trials A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente)

    E. Mari;I. Floriani;A. Tinazzi;A. Buda

  • Neuroprotective Effect of Reduced Glutathione on Oxaliplatin-Based Chemotherapy in Advanced Colorectal Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial

    Stefano Cascinu;Vincenzo Catalano;Luigi Cordella;Roberto Labianca

  • Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study)

    C. Pinto;F. Di Fabio;S. Siena;S. Cascinu

  • Epidermal Growth Factor Receptor Gene Copy Number and Clinical Outcome of Metastatic Colorectal Cancer Treated With Panitumumab

    Andrea Sartore-Bianchi;Mauro Moroni;Silvio Veronese;Carlo Carnaghi

  • Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab

    M. Scartozzi;E. Galizia;S. Chiorrini;R. Giampieri

  • PD-1 blockade therapy in renal cell carcinoma: current studies and future promises.

    F Massari;M Santoni;C Ciccarese;D Santini

  • Epidermal Growth Factor Receptor (EGFR) Status in Primary Colorectal Tumors Does Not Correlate With EGFR Expression in Related Metastatic Sites: Implications for Treatment With EGFR-Targeted Monoclonal Antibodies

    Mario Scartozzi;Italo Bearzi;Rossana Berardi;Alessandra Mandolesi

  • Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer.

    Stefano Cascinu;Maria Pia Staccioli;Giampietro Gasparini;Paolo Giordani

  • The evolving role of microsatellite instability in colorectal cancer: A review.

    Fabio Gelsomino;Monica Barbolini;Andrea Spallanzani;Giuseppe Pugliese

  • Recombinant human erythropoietin treatment in cisplatin-associated anemia: a randomized, double-blind trial with placebo.

    S Cascinu;A Fedeli;E Del Ferro;S Luzi Fedeli

  • Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?

    D. Santini;B. Vincenzi;R. Addeo;C. Garufi

  • Phase II study of cetuximab in combination with cisplatin and docetaxel in patients with untreated advanced gastric or gastro-oesophageal junction adenocarcinoma (DOCETUX study)

    C. Pinto;F. Di Fabio;C. Barone;S. Siena

  • Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    S. Cascinu;M. Falconi;Vincenzo Valentini;S. Jelic

  • Pharmacogenetic Profiling and Clinical Outcome of Patients With Advanced Gastric Cancer Treated With Palliative Chemotherapy

    Annamaria Ruzzo;Francesco Graziano;Kazuyuki Kawakami;Go Watanabe

  • Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil.

    Stefano Cascinu;Carlo Aschele;Sandro Barni;Domizia Debernardis

Frequent Co-Authors

Daniele Santini
Daniele Santini Università Campus Bio-Medico
Alfredo Falcone
Alfredo Falcone University of Pisa
Sandro Barni
Sandro Barni Mario Negri Institute for Pharmacological Research
Roberto Labianca
Roberto Labianca Mario Negri Institute for Pharmacological Research
Rodolfo Montironi
Rodolfo Montironi Marche Polytechnic University
Sara Lonardi
Sara Lonardi Istituto Oncologico Veneto
Vittorina Zagonel
Vittorina Zagonel Mario Negri Institute for Pharmacological Research
Nicola Silvestris
Nicola Silvestris University of Messina
Fotios Loupakis
Fotios Loupakis Istituto Oncologico Veneto
Massimo Falconi
Massimo Falconi Vita-Salute San Raffaele University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medicine or healthcare, a variety of related online degrees and career pathways are available. These online programs offer flexibility and a range of specializations to suit differing career goals. If you are pursuing nursing, consider exploring asn to fnp programs to efficiently advance from an associate’s degree in nursing toward becoming a family nurse practitioner.

Those passionate about nutrition or wellness can start their healthcare careers with a bachelor's in nutrition online, preparing for roles in education, research, or health promotion. Accreditation is another critical issue—if you’re considering health administration, it’s essential to ask which online healthcare degree programs are recognized for their accreditation by cahme? to ensure your degree meets industry standards.

For registered nurses who want to advance, some schools now offer online rn-bsn programs without clinicals. These options provide a flexible, accessible way to upgrade qualifications and expand job opportunities without the need for in-person clinical requirements. Exploring these alternatives can provide a fulfilling and adaptable path in the growing healthcare sector.

Best Scientists Citing Stefano Cascinu

Trending Scientists

Recently Published Articles